Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Michel Fagola"'
Publikováno v:
The Lancet. 348:224-228
Summary Background The risk of deep-vein thrombosis (DVT) and pulmonary embolism after total hip replacement (THR) surgery may persist after hospital discharge, but the extent of the risk is not known. We carried out a single-centre, prospective, ran
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::08947c4f5efd13c3a39b2561b766517d
https://doi.org/10.1016/s0140-6736(96)01453-5
https://doi.org/10.1016/s0140-6736(96)01453-5
Autor:
Jean-Yves Darmon, Eric Saliba, Yann Huet, Nicole Vochelle, Delphine Compan, André Planes, Nadine Weisslinger, Michel Fagola, Michel Bellaud
Publikováno v:
Drugs. 52:47-54
Although venous thromboembolism has occasionally been reported after hospital discharge in patients who have undergone total hip replacement (THR), this risk has not been fully quantified and the usefulness of a prophylactic treatment has not been ev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43fdbf48e54c95c2028ac975e07029fd
https://doi.org/10.2165/00003495-199600527-00009
https://doi.org/10.2165/00003495-199600527-00009
Autor:
Michelle Planès, Nicole Vochelle, Michel Fagola, Jacques Féret, Michel Bellaud, André Planes, Claude Salzard
Publikováno v:
The American Journal of Surgery. 161:525-531
Four trials in which enoxaparin, a low-molecular-weight heparin, was used in patients having hip surgery are reported. In the first two trials, enoxaparin was given before general anesthesia. The protocol consisted of 40 mg of enoxaparin, 4,000 anti-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f076b3585d05abb2c0eeccf3df84a8ee
https://doi.org/10.1016/0002-9610(91)91125-3
https://doi.org/10.1016/0002-9610(91)91125-3